ArticleFrontiers in cellular and infection microbiology2025
Analysis of clinical and imaging features and prognosis of patients positive for
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To probe into the application value of nanopore sequencing in patients suffering from positive Methods: This study retrospectively analyzed 2,137 samples subjected to nanopore sequencing at the Fourth People's Hospital of Nanning. Among them, 14 bronchoalveolar lavage fluid (BALF) samples were positive for TW. Patients were divided into a high-sequence group (100) and a low-sequence group (≤100) in accordance with the TW sequence counts. The clinical features, laboratory indicators, imaging manifestations, and treatment prognosis of these two groups were compared and analyzed in an all-round manner. Results: The levels of C-reactive protein (CRP) and lactate dehydrogenase (LDH) in the high-sequence group were strikingly higher than those in the low-sequence group (P < 0.05). Radiologically, TW pneumonia mostly presented as patchy shadows, ground-glass opacities, and bronchiectasis, which highly overlapped with the imaging features of tuberculosis or interstitial pneumonia. With respect to treatment, 85.7% of the 14 patients exhibited symptomatic improvement subsequent to antibiotic treatment. Fluoroquinolones and combination therapy regimens demonstrated satisfactory efficacy, but patients suffering from severe conditions or advanced age may require an extended treatment course. Conclusion: The imaging manifestations of TW pneumonia are not only non-specific but also have been frequently mistaken with other pulmonary diseases. Notwithstanding the fact that fluoroquinolones and combination therapy regimens hold clinical relevance in the management of Whipple's disease, tailored adjustments to treatment plans are crucial based on individual patient circumstances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.